Femasys Inc. (FEMY) NASDAQ
0.38
-0.0091(-2.35%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.38
-0.0091(-2.35%)
Currency In USD
Address
3950 Johns Creek Court
Suwanee, GA 30024
United States of America (the)
Phone
770 500 3910
Website
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
69
First IPO Date
June 18, 2021
| Name | Title | Pay | Year Born |
| Kathy Lee-Sepsick | Founder, President, Chief Executive Officer & Director | 661,217 | 1968 |
| Dov Elefant | Chief Financial Officer | 548,804 | 1967 |
| Jeffrey Marcus | Chief Medical Advisor | 0 | N/A |
| Benjamin Dings | Vice President of Sales | 0 | N/A |
| Jeremy Alexander Sipos | Chief Technology Officer | 0 | 1974 |
| Mary An Merchant | Vice President of Counsel & Intellectual Property | 0 | N/A |
| John Canning | Chief Operating Officer | 0 | 1974 |
| Christine Thomas | Senior Vice President of Regulatory & Clinical Affairs | 0 | 1973 |
| Megan Eckerman | Senior Vice President of Global Marketing | 0 | N/A |
| James H. Liu | Chief Medical Officer | 0 | N/A |
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.